Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013392029> ?p ?o ?g. }
- W2013392029 endingPage "444" @default.
- W2013392029 startingPage "436" @default.
- W2013392029 abstract "Summary. Hydroxyurea therapy reduces the rates of vaso‐occlusive crisis in patients with sickle cell anaemia and recent data suggest that hydroxyurea treatment can generate nitric oxide (NO). Nitric oxide has been proposed as a novel therapy for sickle cell disease via a number of pathways. We therefore sought to determine whether hydroxyurea has NO donor properties in patients with sickle cell anaemia and explore potential mechanisms by which NO production could be therapeutic. Venous blood was collected from 19 fasting sickle cell anaemia patients, on chronic hydroxyurea therapy, at baseline and 2 and 4 h after a single morning dose of hydroxyurea, as well as 10 patients not taking hydroxyurea. The plasma and red cell NO reaction products nitrate, nitrite and nitrosylated‐ haemoglobin were measured using ozone‐based chemiluminescent assays (using vanadium, KI and I 3 – reductants respectively). Consistent with NO release from hydroxyurea, baseline levels of total nitrosylated haemoglobin increased from 300 nmol/l to 500 nmol/l ( P = 0·01). Plasma nitrate and nitrite levels also significantly increased with peak levels observed at 2 h. Glutathionyl–haemoglobin levels were unchanged, while plasma secretory vascular cellular adhesion molecule‐1 levels were reduced in patients taking hydroxyurea (419 ± 40 ng/ml) compared with control patients with sickle cell anaemia (653 ± 55 ng/ml; P = 0·003), and were inversely correlated with fetal haemoglobin levels ( r = −0·72; P = 0·002). These results demonstrate that hydroxyurea therapy is associated with the intravascular and intraerythrocytic generation of NO. The role of NO in the induction of fetal haemoglobin and possible synergy between NO donor therapy and classic cytostatic and differentiating medications should be explored." @default.
- W2013392029 created "2016-06-24" @default.
- W2013392029 creator A5007944034 @default.
- W2013392029 creator A5012455824 @default.
- W2013392029 creator A5012634036 @default.
- W2013392029 creator A5020236764 @default.
- W2013392029 creator A5021207027 @default.
- W2013392029 creator A5022606690 @default.
- W2013392029 creator A5029041351 @default.
- W2013392029 creator A5069121564 @default.
- W2013392029 creator A5070078534 @default.
- W2013392029 creator A5076239225 @default.
- W2013392029 creator A5084812922 @default.
- W2013392029 date "2002-02-01" @default.
- W2013392029 modified "2023-10-17" @default.
- W2013392029 title "Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease" @default.
- W2013392029 cites W1575180462 @default.
- W2013392029 cites W1580076592 @default.
- W2013392029 cites W1639516662 @default.
- W2013392029 cites W1872047122 @default.
- W2013392029 cites W1912923296 @default.
- W2013392029 cites W1968141837 @default.
- W2013392029 cites W1969489400 @default.
- W2013392029 cites W1978949176 @default.
- W2013392029 cites W1981716766 @default.
- W2013392029 cites W1984018972 @default.
- W2013392029 cites W1986005376 @default.
- W2013392029 cites W1986059506 @default.
- W2013392029 cites W1999129326 @default.
- W2013392029 cites W2005466083 @default.
- W2013392029 cites W2010715396 @default.
- W2013392029 cites W2015295078 @default.
- W2013392029 cites W2021648652 @default.
- W2013392029 cites W2021801016 @default.
- W2013392029 cites W2029953380 @default.
- W2013392029 cites W2033240573 @default.
- W2013392029 cites W2048403134 @default.
- W2013392029 cites W2052030086 @default.
- W2013392029 cites W2052895486 @default.
- W2013392029 cites W2055403815 @default.
- W2013392029 cites W2055403900 @default.
- W2013392029 cites W2056607793 @default.
- W2013392029 cites W2056794597 @default.
- W2013392029 cites W2061188498 @default.
- W2013392029 cites W2067738744 @default.
- W2013392029 cites W2068463090 @default.
- W2013392029 cites W2095115132 @default.
- W2013392029 cites W2099094190 @default.
- W2013392029 cites W2127479364 @default.
- W2013392029 cites W2131868847 @default.
- W2013392029 cites W2150182456 @default.
- W2013392029 cites W2163889067 @default.
- W2013392029 cites W2171351423 @default.
- W2013392029 cites W2174238176 @default.
- W2013392029 cites W2313541759 @default.
- W2013392029 cites W2329201830 @default.
- W2013392029 cites W2338703905 @default.
- W2013392029 cites W2460895384 @default.
- W2013392029 cites W27650594 @default.
- W2013392029 cites W3113247834 @default.
- W2013392029 cites W4238247142 @default.
- W2013392029 cites W4252782797 @default.
- W2013392029 cites W7055056 @default.
- W2013392029 doi "https://doi.org/10.1046/j.1365-2141.2002.03274.x" @default.
- W2013392029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11841449" @default.
- W2013392029 hasPublicationYear "2002" @default.
- W2013392029 type Work @default.
- W2013392029 sameAs 2013392029 @default.
- W2013392029 citedByCount "196" @default.
- W2013392029 countsByYear W20133920292012 @default.
- W2013392029 countsByYear W20133920292013 @default.
- W2013392029 countsByYear W20133920292014 @default.
- W2013392029 countsByYear W20133920292015 @default.
- W2013392029 countsByYear W20133920292016 @default.
- W2013392029 countsByYear W20133920292017 @default.
- W2013392029 countsByYear W20133920292018 @default.
- W2013392029 countsByYear W20133920292019 @default.
- W2013392029 countsByYear W20133920292020 @default.
- W2013392029 countsByYear W20133920292021 @default.
- W2013392029 countsByYear W20133920292022 @default.
- W2013392029 countsByYear W20133920292023 @default.
- W2013392029 crossrefType "journal-article" @default.
- W2013392029 hasAuthorship W2013392029A5007944034 @default.
- W2013392029 hasAuthorship W2013392029A5012455824 @default.
- W2013392029 hasAuthorship W2013392029A5012634036 @default.
- W2013392029 hasAuthorship W2013392029A5020236764 @default.
- W2013392029 hasAuthorship W2013392029A5021207027 @default.
- W2013392029 hasAuthorship W2013392029A5022606690 @default.
- W2013392029 hasAuthorship W2013392029A5029041351 @default.
- W2013392029 hasAuthorship W2013392029A5069121564 @default.
- W2013392029 hasAuthorship W2013392029A5070078534 @default.
- W2013392029 hasAuthorship W2013392029A5076239225 @default.
- W2013392029 hasAuthorship W2013392029A5084812922 @default.
- W2013392029 hasBestOaLocation W20133920291 @default.
- W2013392029 hasConcept C126322002 @default.
- W2013392029 hasConcept C134018914 @default.
- W2013392029 hasConcept C1491633281 @default.
- W2013392029 hasConcept C172680121 @default.